Intestinal microbiota as modulators of the immune system

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Sánchez, Borja ^a   Gueimonde, Miguel ^b   Peña, Amado Salvador ^c   Bernardo, David ^d  

^a UNIVERSITY OF VIGO   (Spain)

^b DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ST MARK S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; PREBIOTIC AGENT; PROBIOTIC AGENT;

ANTIGEN PRESENTING CELL; COMMENSAL; DENDRITIC CELL; EDITORIAL; HELICOBACTER INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOMODULATION; INTESTINE FLORA; NONHUMAN; REGULATORY T LYMPHOCYTE; TH17 CELL; ANIMAL; IMMUNE SYSTEM; IMMUNOLOGY; INTESTINE MUCOSA; MICROBIOLOGY;

ANIMALS; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNE SYSTEM; IMMUNOMODULATION; INTESTINAL MUCOSA;

EID: 84925299868     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/159094     Document Type: Editorial

References (23)

1. T. T. MacDonald, I. Monteleone, M. C. Fantini, and G. Monteleone, "Regulation of homeostasis and inflammation in the intestine," Gastroenterology, vol. 140, no. 6, pp. 1768-1775, 2011.
2. A. M. Mowat, "Anatomical basis of tolerance and immunity to intestinal antigens," Nature Reviews Immunology, vol. 3, no. 4, pp. 331-341, 2003.
3. G. A. W. Rook, C. L. Raison, and C. A. Lowry, "Microbial 'old friends', immunoregulation and socioeconomic status," Clinical & Experimental Immunology, vol. 177, no. 1, pp. 1-12, 2014.
4. L. C. Osborne, L. A. Monticelli, T. J. Nice et al., "Virus-helminth coinfection reveals a microbiota-independent mechanism of immunomodulation," Science, vol. 345, no. 6196, pp. 578-582, 2014.
5. A. Mortha, A. Chudnovskiy, D. Hashimoto et al., "Microbiotadependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis," Science, vol. 343, no. 6178, Article ID 1249288, 2014.
6. S. El Aidy, P. van Baarlen, M. Derrien et al., "Temporal and spatial interplay of microbiota and intestinal mucosa drive establishment of immune homeostasis in conventionalized mice," Mucosal Immunology, vol. 5, no. 5, pp. 567-579, 2012.
7. E. Holmes, J. Kinross, G. R. Gibson et al., "Therapeutic modulation of microbiota-host metabolic interactions," Science Translational Medicine, vol. 4, no. 137, p. 137rv6, 2012.
8. C. Manichanh, N. Borruel, F. Casellas, and F. Guarner, "The gut microbiota in IBD," Nature Reviews Gastroenterology and Hepatology, vol. 9, no. 10, pp. 599-608, 2012.
9. J. K. Nicholson, E. Holmes, J. Kinross et al., "Host-gut microbiota metabolic interactions," Science, vol. 336, no. 6086, pp. 1262-1267, 2012.
10. E. van Nood, M. G. W. Dijkgraaf, and J. J. Keller, "Duodenal infusion of feces for recurrent Clostridium difficile," The New England Journal of Medicine, vol. 368, no. 22, pp. 2143-2145, 2013.
11. S. Yu, A. Abdelkarim, A. Nawras et al., "Fecal transplant for treatment of toxic megacolon associated with clostridium difficile colitis in a patient with duchenne muscular dystrophy," American Journal of Therapeutics, 2014.
12. Z. Kassam, C. H. Lee, and R.H. Hunt, "Reviewof the emerging treatment of Clostridiumdifficile infection with fecal microbiota transplantation and insights into future challenges," Clinics in Laboratory Medicine, vol. 34, no. 4, pp. 787-798, 2014.
13. L. M. M. Costes, G. E. Boeckxstaens, W. J. de Jonge, and C. Cailotto, "Neural networks in intestinal immunoregulation," Organogenesis, vol. 9, no. 3, pp. 216-223, 2013.
14. S. D. Udayappan, A. V. Hartstra, G. M. Dallinga-Thie, and M. Nieuwdorp, "Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus," Clinical & Experimental Immunology, vol. 177, no. 1, pp. 24-29, 2014.
15. G. Vitaliti, P. Pavone, F. Guglielmo, G. Spataro, and R. Falsaperla, "The immunomodulatory effect of probiotics beyond atopy: an update," Journal of Asthma, vol. 51, no. 3, pp. 320-332, 2014.
16. R. Ashraf and N. P. Shah, "Immune system stimulation by probiotic microorganisms," Critical Reviews in Food Science and Nutrition, vol. 54, no. 7, pp. 938-956, 2014.
17. S. K. Hegazy and M. M. El-Bedewy, "Effect of probiotics on pro-inflammatory cytokines and NF-κb activation in ulcerative colitis," World Journal of Gastroenterology, vol. 16, no. 33, pp. 4145-4151, 2010.
18. M. E. Baldassarre, N. Laforgia, M. Fanelli, A. Laneve, R. Grosso, and C. Lifschitz, "Lactobacillus GG improves recovery in infants with blood in the stools and presumptive allergic colitis compared with extensively hydrolyzed formula alone," The Journal of Pediatrics, vol. 156, no. 3, pp. 397-401, 2010.
19. C. A. Lozupone, M. E. Rhodes, C. P. Neff, A. P. Fontenot, T. B. Campbell, and B. E. Palmer, "HIV-induced alteration in gut microbiota: driving factors, consequences, and effects of antiretroviral therapy," GutMicrobes, vol. 5, no. 4, pp. 562-570, 2014.
20. Z. Shu, J. Ma, D. Tuerhong, C. Yang, and H. Upur, "How intestinal bacteria can promote HIV replication," AIDS Reviews, vol. 15, no. 1, pp. 32-37, 2013.
21. M. Rescigno, M. Urbano, B. Valzasina et al., "Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria," Nature Immunology, vol. 2, no. 4, pp. 361-367, 2001.
22. F. Granucci, C. Vizzardelli, N. Pavelka et al., "Inducible IL-2production by dendritic cells revealed by global gene expression analysis," Nature Immunology, vol. 2, no. 9, pp. 882-888, 2001.
23. + onthe expressionof selected superficialmolecules on monocyte and lymphocyte and the synthesis of cytokines in whole blood culture," Journal of Physiology and Pharmacology, vol. 63, no. 3, pp. 217-224, 2012.